WithdrawnPhase 4ACTRN12609000278235

The effect of zoledronate on cardiovascular protection in osteoporotic elderly patients who have suffered a hip fracture.

A randomised, double-blind, placebo-controlled trial to determine the effect of zoledronate on endothelial dysfunction in osteoporotic elderly patients who have suffered a hip fracture

Sponsor

A/Prof. Gustavo Duque

Enrollment

60 participants

Start Date

Jun 1, 2009

Study Type

Interventional

Conditions

Endothelial Dysfunction

Summary

This is a one year study to identify the effect of Zoledronate on endothelial dysfunction, a marker or cardiovascular risk.

Eligibility

Sex: Both males and femalesMin Age: 65 YearssMax Age: 100 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether zoledronate (a bone-strengthening infusion) can also protect heart and blood vessel health in elderly patients (65-100) with osteoporosis who have had a hip fracture in the past year. Participants receive the medication and are monitored for both bone and cardiovascular outcomes.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Zoledronic acid 5 mg in 100 mL, intravenous, infused over 30 minutes, single dose.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609000278235

Related Trials

Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia

NCT032554081 location

Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research

NCT032537051 location

Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal

NCT059399341 location

TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD

NCT074873631 location

TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

NCT074609601 location